deltatrials
Completed PHASE3 NCT00002874

Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy

A PHASE III TRIAL OF RADIATION THERAPY WITH OR WITHOUT CASODEX IN PATIENTS WITH PSA ELEVATION FOLLOWING RADICAL PROSTATECTOMY FOR pT3N0 CARCINOMA OF THE PROSTATE

Sponsor: NRG Oncology

Conditions Prostate Cancer
Interventions bicalutamide placebo radiation therapy
Updated 16 times since 2017 Last updated: May 23, 2022 Started: Feb 28, 1998 Primary completion: Aug 31, 2015 Completion: May 20, 2022

This PHASE3 trial investigates Prostate Cancer and is currently completed. NRG Oncology leads this study, which shows 16 recorded versions since 1998 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

16 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. May 2023 — Jul 2024 [monthly]

    Completed PHASE3

  5. Jul 2022 — May 2023 [monthly]

    Completed PHASE3

    Status: Unknown Status → Completed

▶ Show 11 earlier versions

  1. Apr 2022 — Jul 2022 [monthly]

    Unknown Status PHASE3

  2. Oct 2021 — Apr 2022 [monthly]

    Unknown Status PHASE3

    Status: Active Not Recruiting → Unknown Status

  3. Jan 2021 — Oct 2021 [monthly]

    Active Not Recruiting PHASE3

  4. Sep 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE3

  5. Dec 2019 — Sep 2020 [monthly]

    Active Not Recruiting PHASE3

  6. Mar 2019 — Dec 2019 [monthly]

    Active Not Recruiting PHASE3

  7. Jun 2018 — Mar 2019 [monthly]

    Active Not Recruiting PHASE3

  8. Sep 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE3

  9. Jun 2017 — Sep 2017 [monthly]

    Active Not Recruiting PHASE3

  10. Feb 2017 — Jun 2017 [monthly]

    Active Not Recruiting PHASE3

  11. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE3

    First recorded

Feb 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • NRG Oncology
  • National Cancer Institute (NCI)
  • Radiation Therapy Oncology Group
  • SWOG Cancer Research Network
Data source: Radiation Therapy Oncology Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Akron, United States, Albany, United States, Albuquerque, United States, Allentown, United States, Amarillo, United States, Anderson, United States, Ann Arbor, United States, Annapolis, United States, Arlington Heights, United States, Atlanta, United States and 171 more location s